SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-025876
Filing Date
2009-05-13
Accepted
2009-05-13 06:19:49
Documents
15
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v148883_10k.htm 10-K 1860888
2 GRAPHIC pg12.jpg GRAPHIC 27920
3 GRAPHIC pg14a.jpg GRAPHIC 25639
4 GRAPHIC pg14b.jpg GRAPHIC 22746
5 GRAPHIC pg15.jpg GRAPHIC 15372
6 GRAPHIC pg18.jpg GRAPHIC 90242
7 GRAPHIC pg20.jpg GRAPHIC 26717
8 GRAPHIC pg22a.jpg GRAPHIC 61288
9 GRAPHIC pg22b.jpg GRAPHIC 48538
10 v148883_ex21-1.htm EX-21.1 7294
11 v148883_ex23-1.htm EX-23.1 2763
12 v148883_ex31-1.htm EX-31.1 21010
13 v148883_ex31-2.htm EX-31.2 21000
14 v148883_ex32-1.htm EX-32.1 6665
15 v148883_ex32-2.htm EX-32.2 6687
  Complete submission text file 0001144204-09-025876.txt   2367649
Mailing Address 2085?B? QUAKER POINT DRIVE QUAKERTOWN PA 18951
Business Address 2085?B? QUAKER POINT DRIVE QUAKERTOWN PA 18951 215-529-6084
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26372 | Film No.: 09820407
SIC: 2834 Pharmaceutical Preparations